Open AccessShort bevacizumab infusion as an effective and safe treatment for colorectal cancer
Author(s) -
Koichi Taira,
Shunsuke Okazaki,
Kohei Akiyoshi,
Hirohisa Machida,
Tetsuro Ikeya,
Akie Kimura,
Akinobu Nakata,
Yuji Nadatani,
Masaki Ohminami,
Shusei Fukunaga,
Koji Otani,
Shuhei Hosomi,
Fumio Tanaka,
Noriko Kamata,
Yasuaki Nagami,
Yasuhiro Fujiwara
Publication year - 2022
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2022.2572
Subject(s) - bevacizumab , medicine , colorectal cancer , interquartile range , clinical endpoint , adverse effect , ovarian cancer , perforation , cancer , gastroenterology , surgery , chemotherapy , anesthesia , randomized controlled trial , materials science , punching , metallurgy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom